跳至主要内容
临床试验/ISRCTN14558398
ISRCTN14558398已完成不适用

Modification of chronic oral nonsteroidal anti-inflammatory drug (NSAID) requirement; feasibility, patient benefit and cost-effectiveness.

HS R&D Regional Programme Register - Department of Health (UK)0 个研究点目标入组 260 人开始时间: 2004年1月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
260

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Two general practices with computer generated register data will be invited to participate. Up to 260 patients receiving regular prescriptions for NSAIDs for regional locomotor pain will be identified according to the following criteria.
  • 1. Adult (18 years or older, no upper age limit)
  • 2. Oral NSAID prescriptions to cover at least 6 of the previous 12 months
  • 3. Last prescription within 6 weeks of induction into study
  • 4. Osteoarthritis or regional locomotor pain (e.g. shoulder lesion, neck pain, back pain) as the reason for prescription

排除标准

  • Defined inflammatory arthritis (e.g. rheumatoid arthritis, ankylosin spondylitis, gout), bone malignancy or non-locomotor pain as reason for prescription (obtained from GP records)

研究者

发起方
HS R&D Regional Programme Register - Department of Health (UK)

相似试验